209 related articles for article (PubMed ID: 26712519)
21. SFRP1 inhibited the epithelial ovarian cancer through inhibiting Wnt/β-catenin signaling.
Zhang H; Sun D; Qiu J; Yao L
Acta Biochim Pol; 2019 Nov; 66(4):393-400. PubMed ID: 31770484
[TBL] [Abstract][Full Text] [Related]
22. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW
Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492
[TBL] [Abstract][Full Text] [Related]
23. A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation.
Kierulf-Vieira KS; Sandberg CJ; Waaler J; Lund K; Skaga E; Saberniak BM; Panagopoulos I; Brandal P; Krauss S; Langmoen IA; Vik-Mo EO
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575464
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/β-catenin signaling.
Wu Q; Yin X; Zhao W; Xu W; Chen L
PLoS One; 2021; 16(12):e0260864. PubMed ID: 34852024
[TBL] [Abstract][Full Text] [Related]
25. IDH1 mutation diminishes aggressive phenotype in glioma stem cells.
Yao Q; Cai G; Yu Q; Shen J; Gu Z; Chen J; Shi W; Shi J
Int J Oncol; 2018 Jan; 52(1):270-278. PubMed ID: 29115585
[TBL] [Abstract][Full Text] [Related]
26. Korean Red ginseng extract inhibits glioblastoma propagation by blocking the Wnt signaling pathway.
Ham SW; Kim JK; Jeon HY; Kim EJ; Jin X; Eun K; Park CG; Lee SY; Seo S; Kim JY; Choi SH; Hong N; Lee YY; Kim H
J Ethnopharmacol; 2019 May; 236():393-400. PubMed ID: 30878548
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.
De Robertis A; Valensin S; Rossi M; Tunici P; Verani M; De Rosa A; Giordano C; Varrone M; Nencini A; Pratelli C; Benicchi T; Bakker A; Hill J; Sangthongpitag K; Pendharkar V; Liu B; Ng FM; Then SW; Jing Tai S; Cheong SM; He X; Caricasole A; Salerno M
Mol Cancer Ther; 2013 Jul; 12(7):1180-9. PubMed ID: 23619303
[TBL] [Abstract][Full Text] [Related]
28. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
Chua AW; Gan SU; Ting Y; Fu Z; Lim CK; Song C; Sabapathy K; Phan TT
J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
[TBL] [Abstract][Full Text] [Related]
29. [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis].
Ou Y; Jing G; Liu J; Gao S; Cheng Z; Dong X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):854-61. PubMed ID: 26710459
[TBL] [Abstract][Full Text] [Related]
30. Sfrp1 protects against acute myocardial ischemia (AMI) injury in aged mice by inhibiting the Wnt/β-catenin signaling pathway.
Tao J; Wei X; Huang Y; Liu F; Wu Y; Adi D; Xiang Y; Chen Y; Ma YT; Chen BD
J Cardiothorac Surg; 2021 Jan; 16(1):12. PubMed ID: 33468190
[TBL] [Abstract][Full Text] [Related]
31. Netrin-like domain of sFRP4, a Wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG.
Yasmin IA; Mohana Sundaram S; Banerjee A; Varier L; Dharmarajan A; Warrier S
Exp Cell Res; 2021 Dec; 409(2):112912. PubMed ID: 34762897
[TBL] [Abstract][Full Text] [Related]
32. WNT antagonist, SFRP1, is Hedgehog signaling target.
Katoh Y; Katoh M
Int J Mol Med; 2006 Jan; 17(1):171-5. PubMed ID: 16328026
[TBL] [Abstract][Full Text] [Related]
33. Estrogen-mediated signaling is differentially affected by the expression levels of Sfrp1 in mammary epithelial cells.
Gregory KJ; Schneider SS
Cell Biol Int; 2015 Jul; 39(7):873-9. PubMed ID: 25809273
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
35. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
36. Isocostunolide inhibited glioma stem cell by suppression proliferation and inducing caspase dependent apoptosis.
Dai Z; Li SR; Zhu PF; Liu L; Wang B; Liu YP; Luo XD; Zhao XD
Bioorg Med Chem Lett; 2017 Jul; 27(13):2863-2867. PubMed ID: 28487072
[TBL] [Abstract][Full Text] [Related]
37. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
[TBL] [Abstract][Full Text] [Related]
38. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
39. Moesin is a glioma progression marker that induces proliferation and Wnt/β-catenin pathway activation via interaction with CD44.
Zhu X; Morales FC; Agarwal NK; Dogruluk T; Gagea M; Georgescu MM
Cancer Res; 2013 Feb; 73(3):1142-55. PubMed ID: 23221384
[TBL] [Abstract][Full Text] [Related]
40. Wnt/β-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms.
Gao L; Chen B; Li J; Yang F; Cen X; Liao Z; Long X
PLoS One; 2017; 12(8):e0181346. PubMed ID: 28837560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
